Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
217 studies found for:    Open Studies | "Influenza, Human"
Show Display Options
Rank Status Study
21 Recruiting Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG);   Biological: Placebo for IVIG
22 Unknown  Optimizing Influenza Vaccination in Surgical Oncology Patients
Condition: Influenza
Intervention: Biological: Influenza vaccine
23 Recruiting A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza
Condition: Influenza
Interventions: Drug: Oseltamivir;   Drug: MEDI8852;   Drug: Placebo
24 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
25 Unknown  The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients
Conditions: Influenza A;   Swine Flu
Interventions: Dietary Supplement: Pomegranate juice;   Dietary Supplement: Placebo drink
26 Recruiting A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
Condition: Influenza, Human
Interventions: Biological: Seqirus Quadrivalent Inactivated Influenza Vaccine;   Biological: Comparator Quadrivalent Inactivated Influenza Vaccine
27 Recruiting Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry
Conditions: Pregnancy;   Influenza
Intervention: Biological: Quadrivalent Influenza Vaccine (QIV)
28 Recruiting Immunogenicity of Influenza Vaccine in Long Term Care
Condition: Influenza
Intervention: Procedure: Blood Draw
29 Recruiting Banlangen Granules Anti-seasonal Influenza Study
Condition: Influenza
Interventions: Drug: placebo of oseltamivir phosphate;   Drug: oseltamivir phosphate;   Drug: Banlangen (Radix Isatidis) granules;   Drug: placebo of Banlangen(Radix Isatidis) granules
30 Recruiting Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Conditions: Pregnancy;   Influenza
Intervention: Biological: Quadrivalent Intradermal Influenza Vaccine (QIV)
31 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
32 Recruiting Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
Conditions: Vaccination;   Influenza
Interventions: Behavioral: Local educational information;   Behavioral: National educational information
33 Recruiting Influenza in People With Normal and Weakened Immune Systems
Condition: Influenza
34 Recruiting Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India
Condition: Influenza
Intervention: Biological: Quadrivalent Inactivated Influenza Vaccine, No Preservative
35 Recruiting Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
Condition: Influenza
36 Not yet recruiting Asymptomatic Flu Project
Condition: Influenza
Interventions: Biological: Blood sampling;   Other: Nasal swab
37 Recruiting Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
Conditions: Heart Failure;   Influenza
Interventions: Other: Sterile saline;   Drug: inactivated trivalent influenza vaccine
38 Recruiting Respiratory Virus Outpatient Study (FLU 002 Plus)
Condition: Influenza and Other Novel Respiratory Viruses
39 Recruiting Two-site Intradermal Influenza Vaccination in Elderly
Condition: Influenza
Intervention: Biological: seasonal influenza vaccine
40 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years